Smoking-cessation for patients with acute psychiatric illness (original) (raw)
Related papers
Smoking reduction in psychiatric inpatients is feasible: results from a 12-month prospective study
Annals of General Psychiatry, 2015
Background: Despite the fact that smoking is a crucial morbidity factor among psychiatric patients, little progress has been made in order to reduce smoking during psychiatric hospitalization. Methods: We studied the smoking behaviour of patients admitted to a non-smoking psychiatric ward, after monitoring them for smoking habits and helping them cope in order to modify their smoking behaviour. For a period of 12 months, we conducted a prospective study of simple smoking avoidance measures in the 2nd Department of Psychiatry of Attikon University Hospital in Athens. Results: From 330 admitted patients, 170 (51.5%) were smokers; they were monitored for their smoking habits and encouraged by the nursing staff to reduce smoking. The mean number of cigarettes per day (CPD) at admission was 32.2 (sd 22.1) and upon discharge 14.1 (sd 14.8) (t = 11.7, p < 0.001). Most of the smokers, 142 (83.5%), managed to reduce their cigarette consumption per day. Diagnosis did not affect the reduction or increase in CPD. The only factor that predicted reduction in CPD was the female sex. Conclusions: Our findings indicate that seriously mentally ill psychiatric inpatients despite negative preconceptions and stereotypes respond well to simple measures aiming to reduce their smoking and modify their behaviour.
Journal of Environmental Science, 2018
Background: Tobacco use disorders associated with most psychiatric and respiratory disorders smoking ultimately destroy a person's life, rehabilitation and smoke cessation program can save the person's life. Aim Of The Work: assessment of rehabilitation and smoking cessation program and to evaluate the improvement of the patients after following the rehabilitation program. Patients And Methods: This is interventional study was carried on 120 patients collected from the private psychiatric clinicsas a convenience sample selection 120 are tobacco use disorder and had psychiatric disorder. Results: After one year of actual rehabilitation and smoking cessation program show improvement in clinical picture of patients Conclusion: Smoking cessation is associated with improved quality of life compared with continuing to smoke Recomendation: strict regulation should be adopted to prevent mal usage of smoking that lead to dependence and abuse also recommend that future policies should encourage further research into adverse health effects of smoking and the benefits of rehabilitation and smoking cessation.
Journal of Clinical Psychopharmacology, 2020
Background: Effectiveness of nicotine replacement therapies in acute psychiatric inpatient settings remains under-researched. The aim of this study was to compare effectiveness and acceptability of 3 different forms of nicotine replacement therapy in achieving smoking reduction among acute psychiatric inpatients. Methods: This cluster-randomized, parallel study compared effectiveness and acceptability of nicotine inhalers, nicotine gum, and nicotine patches for smoking reduction in the acute psychiatric inpatient setting. The primary outcome was the exhaled breath carbon monoxide (CO) level change from baseline at weeks 4 and 8. Secondary outcomes included changes in nicotine withdrawal symptoms and psychiatric symptom severity. Results: Three hundred ten inpatients on the acute care wards were randomly assigned to nicotine inhalers (n = 184), gum (n = 71), and patches (n = 55). Only the nicotine inhaler group showed statistically significant reduction in CO level from baseline at both weeks 4 and 8 (P < 0.001 and P = 0.032, respectively). The nicotine inhaler and the patch group showed significant decrease in nicotine withdrawal symptoms from baseline at both weeks 4 and 8. Meanwhile, the nicotine inhaler and the gum group showed significant decrease in psychiatric symptom severity from baseline at both weeks 4 and 8. Post hoc comparisons revealed that the inhaler group had a greater decrease in psychiatric symptom severity compared with the patch group. Conclusions: Nicotine inhalers may be an effective choice for smoking reduction in acute psychiatric inpatient settings given its significant effects on CO level, withdrawal symptoms, and psychiatric symptom severity, particularly during the first 4 weeks of treatment.
Smoking Cessation in Patients With Psychiatric Disorders
The Journal of Clinical Psychiatry, 2007
PRETEST AND OBJECTIVES PSYCHIATRIST.COM Articles are selected for credit designation on the basis of the CME Institute's assessment of the needs of readers of The Primary Care Companion, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. There are no prerequisites for participation in this CME activity. To obtain credit, read the material and complete the Posttest and Registration Form on pages 84-85 or go to PSYCHIATRIST.COM and take the Posttest online. CME Objective After studying the Commentary, you should be able to: • Distinguish the reasons that patients with psychiatric disorders smoke, evaluate the effect that smoking has on these patients and their illnesses, and compare smoking cessation strategies.
International Journal of Environmental Research and Public Health
This study aims to understand (a) the prevalence and correlates of smoking in a psychiatric population, (b) factors that encourage smoking cessation, and (c) awareness towards cessation programmes. This study captured data (n = 380) through a modified version of the Global Adult Tobacco Survey (GATS). A descriptive analysis of the data was performed. The prevalence of smoking was 39.5% (n = 150) and 52.3% of the smokers were dependent on nicotine. More than half of the smokers had made at least one attempt to quit in the past 12 months and 56% reported no immediate plans to quit smoking. The awareness towards institutional smoking cessation programmes was fair (44%), with 49.7% of smokers having indicated that they were willing to use the service upon referral. Smokers endorsed that increasing the cost of cigarettes, restricting availability, and increasing knowledge of health harms could encourage smoking cessation. Past smokers reported that self-determination/willpower followed b...
View of hospitalized psychiatric patients on the smoking habit
Smad Revista Eletronica Saude Mental Alcool E Drogas, 2012
This is an exploratory descriptive study with quantitative and qualitative approach, which aims to know the opinion of patients about smoking in the hospital and the degree of dependence on smoking. We used a semi-structured interview and Fagerström questionnaire on smokers. We observed 25 patients: 44.0% with mood disorder, schizophrenia 28.0%, 52.0% 10 or more years of disease, 64.0% 1-5 hospitalizations. Of these, 24.0% were smokers, 83.3% had a high degree of dependence. Most nonsmokers agreed to ban smoking in collective environments, without privileges for the mentally ill. Smokers were shown to be opposed to smoke-free policies, but in favor of nicotine replacement therapy during hospitalization. It is expected the investment of the team in tobacco-free environment, health services and raise awareness of smokers to seek smoking cessation treatment.
Prospective study of provided smoking cessation care in an inpatient psychiatric setting
Journal of Psychosomatic Research, 2018
People with mental health difficulties (MHD) are more likely to smoke and to have smoking-related diseases, yet little research has investigated the provision of smoking cessation care in psychiatric inpatient settings. This study aimed to evaluate current levels of cessation care provided, and 3-month quit-rates, in one such setting in Ireland. Methods: From January to October 2016, inpatients across all 8 adult wards of St Patrick's University Hospital were recruited to participate in a baseline face-to-face survey (N = 246), assessing demographic information, smoking history and quit attempts, motivation to quit, nicotine dependence, attitudes towards cessation advice and actual care received. For baseline current smokers (n = 84) who consented, casenotes were also audited for documentation of smoking status and cessation care (n = 77/84) while quit rates were assessed at three months (n = 72/84), including a carbon monoxide test for those who reported quitting. Results: Current smoking prevalence was 34% (n = 84/246). At baseline 75% of smokers wanted to quit and 48% reported they would like cessation advice while in hospital. Few reported receiving cessation advice from any healthcare professional in the past year (13%), while just 6% had smoking cessation care clearly documented in their casenotes. The 3-month quit-rate was 17%, with a 100% pass rate for those completing an objective CO validation test. Conclusion: Despite a high current smoking prevalence among psychiatric inpatients, and similar motivation and quit rates to other populations, current cessation care rates are low. Smoking cessation care needs to be prioritised in psychiatric settings. By replicating recent general inpatient studies in Ireland [13-15], this study aimed to address the limitations outlined above. We aimed to profile current levels of cessation care in psychiatric settings, attitudes
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014
Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalization and continued postdischarge was effective in reducing smoking behaviors among persons with a mental disorder. A randomized controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101) or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge. Follow-up assessments were conducted at 1 week, 2, 4, and 6 months postdischarge and included abstinence from cigarettes, quit attempts, daily cigarette consumption, and nicotine dependence. Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month fol...
Influence of having a psychiatric diagnosis on smoking cessation
Tobacco Prevention & Cessation, 2017
is an open access, peer-reviewed online journal that encompasses all aspects of tobacco use, prevention and cessation that can promote a tobacco free society. The aim of the journal is to foster, promote and disseminate research involving tobacco use, prevention, policy implementation at a regional, national or international level, disease development-progression related to tobacco use, tobacco use impact from the cellular to the international level and finally the treatment of tobacco attributable disease through smoking cessation.
The Quit Experience and Concerns of Smokers With Psychiatric Illness
American journal of preventive medicine, 2015
The purpose of this study is to better understand the quit experience and concerns of smokers with psychiatric illness (i.e., major depressive, anxiety, psychotic and bipolar disorders) in comparison with those without psychiatric illness. Smokers (N=732) with (n=430, 59%) and without psychiatric illness, recruited between June 2010 and March 2013 to participate in the FLEX (Flexible and Extended Dosing of Nicotine Replacement Therapy [NRT] and Varenicline in Comparison to Fixed-Dose NRT for Smoking Cessation) smoking-cessation trial, completed questionnaires assessing previously used cessation aids and reasons for relapse, and motivation and concerns about their upcoming quit attempt. These supplementary data analyses were conducted in May 2015. The most commonly used cessation methods during previous attempts were nicotine replacement therapy (66.4%), cold turkey (59.7%), and bupropion (34.7%); no group differences were identified. Stress was the most common precipitator of relaps...